Ownership history in MORGAN STANLEY · 11 quarters on record
This page tracks every 13F SEC filing in which MORGAN STANLEY reported a position in CARISMA THERAPEUTICS INC (CARM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q3 | UNCHANGED | 3,185 | — | 0% | 0.00% | $873 | $0.27 |
| 2025 Q2 | REDUCED | 3,185 | -2,500 | -44.0% | 0.00% | $1K | $0.39 |
| 2025 Q1 | UNCHANGED | 5,685 | — | 0% | 0.00% | $2K | $0.31 |
| 2024 Q4 | UNCHANGED | 5,685 | — | 0% | 0.00% | $2K | $0.42 |
| 2024 Q3 | REDUCED | 5,685 | -16,083 | -73.9% | 0.00% | $6K | $0.98 |
| 2024 Q2 | REDUCED | 21,768 | -19,508 | -47.3% | 0.00% | $33K | $1.52 |
| 2024 Q1 | REDUCED | 41,276 | -41,199 | -50.0% | 0.00% | $94K | $2.27 |
| 2023 Q4 | ADDED | 82,475 | +55,546 | +206.3% | 0.00% | $242K | $2.93 |
| 2023 Q3 | REDUCED | 26,929 | -5,264 | -16.4% | 0.00% | $114K | $4.23 |
| 2023 Q2 | ADDED | 32,193 | +25,447 | +377.2% | 0.00% | $282K | $8.77 |
As of 2025 Q4 — sorted by position size